Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jacob T. Beaver, Lisa K. Mills, Dominika Swieboda, Nadia Lelutiu, Edward S. Esser, Olivia Q. Antao, Eugenia Scountzou, Dahnide T. Williams, Nikolaos Papaioannou, Elizabeth Q. Littauer, Andrey Romanyuk, Richard W. Compans, Mark R. Prausnitz & Ioanna Skountzou. (2020) Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies. Human Vaccines & Immunotherapeutics 16:9, pages 2072-2091.
Read now
Read now
Franck Touret, Magali Gilles, Raphaelle Klitting, Fabien Aubry, Xavier de Lamballerie & Antoine Nougairède. (2018) Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone. Emerging Microbes & Infections 7:1, pages 1-12.
Read now
Read now
Articles from other publishers (38)
Iris Valdes, Lázaro Gil, Laura Lazo, Karem Cobas, Yaremis Romero, Andy Bruno, Edith Suzarte, Yusleidi Pérez, Ania Cabrales, Yassel Ramos, Lisset Hermida & Gerardo Guillén. (2023) Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice. Vaccine 41:40, pages 5892-5900.
Crossref
Crossref
Daniil V. Shanshin, Sophia S. Borisevich, Alexander A. Bondar, Yuri B. Porozov, Elena A. Rukhlova, Elena V. Protopopova, Nikita D. Ushkalenko, Valery B. Loktev, Andrei I. Chapoval, Alexander A. Ilyichev & Dmitriy N. Shcherbakov. (2022) Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?. International Journal of Molecular Sciences 23:14, pages 7721.
Crossref
Crossref
Kehui Zhou, Chaoqun Li, Wen Shi, Xiaodan Hu, Kutty Selva Nandakumar, Shibo Jiang & Naru Zhang. (2021) Current Progress in the Development of Zika Virus Vaccines. Vaccines 9:9, pages 1004.
Crossref
Crossref
Srividhya Venkataraman, Kathleen Hefferon, Abdullah Makhzoum & Mounir Abouhaidar. (2021) Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?. Vaccines 9:7, pages 761.
Crossref
Crossref
Marco Aurélio Palazzi Sáfadi, Flavia J. Almeida & Renato de Ávila Kfouri. (2021) Zika virus outbreak in Brazil—Lessons learned and perspectives for a safe and effective vaccine. The Anatomical Record 304:6, pages 1194-1201.
Crossref
Crossref
Kelly McBroom. (2021) A Comparison of Zika Virus and COVID‐19: Clinical Overview and Public Health Messaging. Journal of Midwifery & Women's Health 66:3, pages 334-342.
Crossref
Crossref
V. S. Nesmeianova, D. N. Sherbakov & E. I. Kazachinskaia. (2021) Using Flavivirus-Specific Monoclonal Antibodies to Study the Antigenic Structure of Flaviviruses and Develop Anti-Flavivirus Drugs. Molecular Genetics, Microbiology and Virology 36:2, pages 57-67.
Crossref
Crossref
E. I. Kazachinskaya, V. S. Aripov, A. V. Zaikovskaya & A. M. Shestopalov. (2021) Lassa virus: characterization of infectious agent, biological models for pathogenesis studies and variants of vaccine. Medical Immunology (Russia) 23:1, pages 35-48.
Crossref
Crossref
V.S. Nesmeianova, D.N. Sherbakov & E.I. Kazachinskaia. (2021) The use of monoclonal antibodies specific to flavivirus to develop therapeutic drugs. Molecular Genetics Microbiology and Virology (Russian version) 39:2, pages 3.
Crossref
Crossref
Dan Luo, Yuanjiu Miao, Xianliang Ke, Zhongyuan Tan, Chun Hu, Penghui Li, Ting Wang, Yuan Zhang, Jianhong Sun, Yan Liu, Hanzhong Wang & Zhenhua Zheng. (2020) Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model. Virologica Sinica 35:5, pages 637-650.
Crossref
Crossref
Arianna Mahely Hurtado‐Monzón, Carlos Daniel Cordero‐Rivera, Carlos Noe Farfan‐Morales, Juan Fidel Osuna‐Ramos, Luis Adrián De Jesús‐González, José Manuel Reyes‐Ruiz & Rosa María del Ángel. (2020) The role of anti‐flavivirus humoral immune response in protection and pathogenesis. Reviews in Medical Virology 30:4.
Crossref
Crossref
Andrew G. Diamos, Mary D. Pardhe, Haiyan Sun, Joseph G.L. Hunter, Tsafrir Mor, Lydia Meador, Jacquelyn Kilbourne, Qiang Chen & Hugh S. Mason. (2020) Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity. Vaccine 38:18, pages 3455-3463.
Crossref
Crossref
Jin Sun, Senyan Du, Zhihang Zheng, Gong Cheng & Xia Jin. (2020) Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade. Frontiers in Microbiology 11.
Crossref
Crossref
Valérie Lecouturier, Vincent Pavot, Catherine Berry, Arnaud Donadieu, Aymeric de Montfort, Florence Boudet, Bachra Rokbi, Nicolas Jackson & Jon Heinrichs. (2020) An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques. npj Vaccines 5:1.
Crossref
Crossref
Yixuan Wang, Rui Zhou, Yanni Quan, Shumin Chen, Xingpeng Shi, Yanping Li & Shan Cen. (2020) Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors. Bioorganic & Medicinal Chemistry Letters 30:4, pages 126906.
Crossref
Crossref
Affan Shoukat, Thomas Vilches & Seyed M. Moghadas. (2019) Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas. Emerging Infectious Diseases 25:12, pages 2191-2196.
Crossref
Crossref
Wei Zhang, Panke Qu, Dapeng Li, Chao Zhang, Qingwei Liu, Gang Zou, Myrielle Dupont-Rouzeyrol, Dimitri Lavillette, Xia Jin, Feifei Yin & Zhong Huang. (2019) Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection. Antiviral Research 170, pages 104578.
Crossref
Crossref
Sasha R. Azar & Scott C. Weaver. (2019) Vector Competence: What Has Zika Virus Taught Us?. Viruses 11:9, pages 867.
Crossref
Crossref
Joel N. Maslow. (2019) Zika Vaccine Development—Current Progress and Challenges for the Future. Tropical Medicine and Infectious Disease 4:3, pages 104.
Crossref
Crossref
E. I. Kazachinskaya, D. V. Shan’shin & A. V. Ivanova. (2019) Zika Fever: Development of Diagnostics, Prevention and Treatment. Problems of Particularly Dangerous Infections:2, pages 6-13.
Crossref
Crossref
Valérie Lecouturier, Marie-Clotilde Bernard, Catherine Berry, Sébastien Carayol, Eric Richier, Florence Boudet & Jon Heinrichs. (2019) Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice. Vaccine 37:20, pages 2679-2686.
Crossref
Crossref
Tanya R Myers, Natalie L McCarthy, Lakshmi Panagiotakopoulos & Saad B Omer. (2019) Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United States. Open Forum Infectious Diseases 6:3.
Crossref
Crossref
Affan Shoukat, Thomas Vilches & Seyed M. Moghadas. (2018) Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia. BMC Medicine 16:1.
Crossref
Crossref
Annelies Wilder-Smith, Kirsten Vannice, Anna Durbin, Joachim Hombach, Stephen J. Thomas, Irani Thevarjan & Cameron P. Simmons. (2018) Zika vaccines and therapeutics: landscape analysis and challenges ahead. BMC Medicine 16:1.
Crossref
Crossref
Sasha Azar, Shannan Rossi, Sherry Haller, Ruimei Yun, Jing Huang, Jessica Plante, Jiehua Zhou, Juan Olano, Christopher Roundy, Kathryn Hanley, Scott Weaver & Nikos Vasilakis. (2018) ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques. Viruses 10:11, pages 661.
Crossref
Crossref
Harapan Harapan, Mudatsir Mudatsir, Amanda Yufika, Yusuf Nawawi, Nur Wahyuniati, Samsul Anwar, Fitria Yusri, Novi Haryanti, Nanda Wijayanti, Rizal Rizal, Devi Fitriani, Nurul Maulida, Muhammad Syahriza, Ikram Ikram, Try Fandoko, Muniati Syahadah, Febrivan Asrizal, Kurnia Jamil, Yogambigai Rajamoorthy, Abram Wagner, David Groneberg, Ulrich Kuch, Ruth Müller, R. Sasmono & Allison Imrie. (2018) Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study. Viruses 10:11, pages 648.
Crossref
Crossref
Himanshu Garg, Tugba Mehmetoglu-Gurbuz & Anjali Joshi. (2018) Recent Advances in Zika Virus Vaccines. Viruses 10:11, pages 631.
Crossref
Crossref
Maryann Giel-Moloney, Ana P. Goncalvez, John Catalan, Valerie Lecouturier, Yves Girerd-Chambaz, Fernando Diaz, Francisco Maldonado-Arocho, Raul C. Gomila, Marie-Clotilde Bernard, Ray Oomen, Simon Delagrave, Nicolas Burdin, Harold Kleanthous, Nicolas Jackson, Jon Heinrichs & Konstantin V. Pugachev. (2018) Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine. Scientific Reports 8:1.
Crossref
Crossref
Paolo Marinho de Andrade Zanotto & Luciana Cezar de Cerqueira Leite. (2018) The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil. Frontiers in Immunology 9.
Crossref
Crossref
Sonja Emily Leonhard, Suzannah Lant, Bart C Jacobs, Annelies Wilder-Smith, Maria Lucia Brito Ferreira, Tom Solomon & Hugh John Willison. (2018) Zika virus infection in the returning traveller: what every neurologist should know. Practical Neurology 18:4, pages 271-277.
Crossref
Crossref
James R. Bowen, Matthew G. Zimmerman & Mehul S. Suthar. (2018) Taking the defensive: Immune control of Zika virus infection. Virus Research 254, pages 21-26.
Crossref
Crossref
Jacob T. Beaver, Nadia Lelutiu, Rumi Habib & Ioanna Skountzou. (2018) Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development. Frontiers in Immunology 9.
Crossref
Crossref
Jessica E Manning, David M Morens, Shaden Kamhawi, Jesus G Valenzuela & Matthew Memoli. (2018) Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?. The Journal of Infectious Diseases 218:1, pages 7-15.
Crossref
Crossref
Ran Wang, Xianzheng Liao, Dongying Fan, Lei Wang, Ji Song, Kaihao Feng, Mingyuan Li, Peigang Wang, Hui Chen & Jing An. (2018) Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. Vaccine 36:24, pages 3522-3532.
Crossref
Crossref
Shiyu Dai, Tao Zhang, Yanfang Zhang, Hualin Wang & Fei Deng. (2018) Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice. Virologica Sinica 33:3, pages 213-226.
Crossref
Crossref
Adriana Goncalves, Rosanna W Peeling, May C Chu, Duane J Gubler, Aravinda M de Silva, Eva Harris, Maurine Murtagh, Arlene Chua, William Rodriguez, Cassandra Kelly & Annelies Wilder-Smith. (2018) Innovative and New Approaches to Laboratory Diagnosis of Zika and Dengue: A Meeting Report. The Journal of Infectious Diseases 217:7, pages 1060-1068.
Crossref
Crossref
Lalita Priyamvada, Mehul S Suthar, Rafi Ahmed & Jens Wrammert. (2017) Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity. The Journal of Infectious Diseases 216:suppl_10, pages S906-S911.
Crossref
Crossref
Peter Abbink, Rafael A. LaroccaKittipos Visitsunthorn, Michael Boyd, Rafael A. De La BarreraGregory D. GromowskiMarinela KirilovaRebecca Peterson, Zhenfeng LiOvini Nanayakkara, Ramya NityanandamNoe B. Mercado, Erica N. BorducchiAbishek ChandrashekarDavid Jetton, Shanell Mojta, Priya Gandhi, Jake LeSuer, Shreeya KhatiwadaMark G. Lewis, Kayvon Modjarrad, Richard G. Jarman, Kenneth H. EckelsStephen J. Thomas, Nelson L. Michael & Dan H. Barouch. (2017) Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Science Translational Medicine 9:420.
Crossref
Crossref